The protective effect of parthenolide in an in vitro model of Parkinson's disease through its regulation of nuclear factor-kappa B and oxidative stress

Seyed Ali Shariat Razavi,Farzane Vafaei,Seyyed Moein Ebrahimi,Farzaneh Abbasinezhad-Moud,Ali Shahini,Farid Qoorchi Moheb Seraj,Mohaddeseh Sadat Alavi,Arghavan Fadavieslam,Gordon A. Ferns,Afsane Bahrami
DOI: https://doi.org/10.1007/s11033-024-09779-w
IF: 2.7422
2024-07-18
Molecular Biology Reports
Abstract:Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure. We have investigated the protective effects of parthenolide (PTN), a compound with known anti-inflammatory and antioxidant properties, in an in vitro model of PD, that is induced by 6-OHDA, and that causes neurotoxicity in SH-SY5Y human neuroblastoma cells.
biochemistry & molecular biology
What problem does this paper attempt to address?